Activity Overview
The Medical Crossfire® is a video-based program in which a panel of distinguished experts discusses a particular clinical topic. In this activity, 3 key thought leaders explore the latest data on current and emerging therapeutic strategies for managing multiple sclerosis (MS) in a variety of patients and across lines of care. This lively discussion will help place new developments into a clinical context to help you optimize care for your patients with MS.
Target Audience
This educational activity is directed toward neurologists, neuromuscular specialists, immunologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of MS.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate how real-world evidence can inform personalized MS treatment decisions
- Develop personalized treatment plans for patients with MS
- Apply shared decision-making strategies to counsel patients with MS
Benjamin Greenberg, MD
Vice Chair of Clinical & Translational Research
Professor
Cain Denius Scholar in Mobility Disorders
Peter O’Donnell Jr Brain Institute
UT Southwestern Medical Center
Dallas, TX
Disclosures: Advisor, Consultant, Fee-for-Service Recipient: Alexion, Amgen, Arialys, Cadenza Bio, Clene, Cycle, EMD Serono, IQVIA, Novartis, PRIME, Sandoz, Sanofi, Sarepta, Signant, TG Therapeutics, Trethera, Zenas; Grant/Research Funding: Bristol Myers Squibb, Genentech, National Institutes of Health; Ownership in Publicly Traded Companies: Clene Nanomedicine; Ownership in Privately Held Companies: GenrAb; Royalty or Patent Benefits: UpToDate
Jiwon Oh, MD
Associate Professor, Division of Neurology
Medical Director, Barlo Multiple Sclerosis Program
St Michael’s Hospital
Toronto, Ontario, Canada
Disclosures: Advisor, Consultant, Fee-for-Service Recipient: Amgen, Bristol Myers Squibb, EMD Serono, Novartis, Roche, Sanofi; Grant/Research Funding: Biogen, Idec, Roche
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, IL
Disclosures: Advisor, Consultant, Fee-for-Service Recipient: Alexion, Amgen, Bristol Myers Squibb, Novartis, Roche, Sandoz, TG Therapeutics, UCB; Speaker’s Bureau: Alexion, Amgen, Bristol Myers Squibb, TG Therapeutics, UCB
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.
This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here